查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1949492

毛細血管採血裝置市場 - 全球產業規模、佔有率、趨勢、機會及預測（按產品、材料、最終用途、應用、地區和競爭格局分類），2021-2031年

Capillary Blood Collection Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Material, By End Use, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球毛細血管採血設備市場預計將從 2025 年的 27.2 億美元成長到 2031 年的 42.7 億美元，複合年成長率為 7.81%。

這些設備由採血針和微量採血管等無菌器械組成，旨在從指尖、足跟或耳垂等部位採集微量血液，用於診斷目的。它們在微創即時診斷測試和患者自我管理中發揮著至關重要的作用。市場成長的主要驅動力是全球慢性病負擔日益加重，這些疾病需要頻繁監測，以及醫療服務向分散化模式的廣泛轉變。需要定期後續觀察的疾病的高發生率凸顯了這種日益成長的需求；例如，國際糖尿病聯盟估計，到2024年，全球將有5.89億成年人患有糖尿病。

市場概覽
預測期 2027-2031
市場規模：2025年 27.2億美元
市場規模：2031年 42.7億美元
複合年成長率：2026-2031年 7.81%
成長最快的細分市場 《採血針》
最大的市場 北美洲

儘管存在這些市場促進因素，但與靜脈採血相比，毛細血管採血在檢體量和檢體完整性方面仍面臨許多挑戰。毛細血管檢體容易出現溶血和組織液污染等分析前問題，這些問題會影響診斷準確性。這些技術限制使得毛細血管採血難以應用於需要更大樣本量和更高品質檢體的複雜檢測。因此，醫療機構往往必須依賴傳統的靜脈穿刺進行全面的臨床評估，從而有效地阻礙了毛細血管採血替代靜脈採血的進程。

市場促進因素

全球感染疾病的日益普及是毛細血管採血裝置市場的主要驅動力，尤其推動了對指尖採血快速診斷檢測的需求。這些微創裝置對於資源匱乏地區的大規模篩檢計畫至關重要，因為在這些地區，傳統的靜脈採血往往成本高昂或操作難度高。在媒介傳播感染疾病的防治中，毛細血管血橫向流動化驗被廣泛用於即時確診和監測。感染帶來的巨大負擔也凸顯了這種高度依賴性。根據世界衛生組織（世衛組織）發布的《2023年世界瘧疾報告》，預計2022年全球瘧疾病例將達到2.49億例，這一數字直接印證了安全採血針和微型採血管的高使用率。

同時，就地檢驗和分散式診斷的興起正在從根本上改變毛細血管採血設備的消費趨勢。醫療系統正在加速從集中式檢查室向非現場篩檢檢測的轉變，以改善患者就醫途徑並加快臨床決策，從而推動了對便捷採血試劑盒的需求激增。這項轉變的背後是解決病毒性疾病診斷缺口的迫切性。根據世界衛生組織（世衛組織）發布的《2024年全球肝炎報告》，僅有36%的C型肝炎病例被診斷，凸顯了普及毛細血管篩檢檢測的迫切需求。支持這些工作的產業規模龐大，貝克頓‧迪金森公司（Becton, Dickinson & Company）2023年生命科學部門51.3億美元的營收便印證了這一點。

市場挑戰

全球毛細血管採血裝置市場成長的主要障礙在於毛細血管採樣固有的樣本完整性問題和有限的採血量。與靜脈採血不同，由於採集過程中需要對組織進行壓迫，毛細血管採血更容易發生溶血和組織間液污染。這些分析前缺陷會顯著降低檢體質量，導致檢體常常不適用於需要高精度和大檢體量的高靈敏度臨床檢測。因此，醫療機構往往不願將這些裝置用於全面的診斷檢測，而主要將其應用限制在血糖監測和基礎篩檢。

這些技術挑戰阻礙了毛細血管採血系統在臨床應用中完全取代傳統的靜脈穿刺，直接限制了市場擴張。由於診斷準確性可能降低，檢查室被迫拒絕受損檢體，導致需要重複採血，加重患者負擔並增加營運成本。近期產業數據凸顯了這個問題的嚴重性。根據ECRI 2024報告，約23%的診斷錯誤與技術或處理失誤（包括檢體品質問題）有關。如此高的錯誤率，加上檢體處理不當，使得醫護人員在進行關鍵醫療決策時，對全面採用毛細血管採血系統持謹慎態度。

市場趨勢

真空輔助上臂採血裝置的興起代表著市場的一項重大進步，有效克服了傳統指尖採血在樣本量和品質方面的限制。與依賴組織壓迫的傳統採血針不同，這些創新裝置利用負壓從上臂毛細血管採集血液，從而能夠獲得與靜脈採血相當的大量檢查室級檢體。這項功能推動了血液採集方式從以診所為基礎向以患者為中心的遠端採血模式轉變，尤其適用於需要超出標準毛細血管採血能力的血清或血漿樣本的慢性病檢測。該技術的商業性成功體現在其快速普及上。 Tasso在2025年3月的新聞稿中宣布，其將售出超過150萬台以患者為中心的裝置，這標誌著該方法在遠距離診斷領域正日益被接受。

同時，體積吸收微量採樣（VAMS）技術的整合正在革新乾血採樣方法，消除了傳統濾紙法中通用的血球比容偏差。 VAMS設備能夠採集固定且精確的血液量，不受血液黏度的影響，從而確保治療藥物監測和藥物研發所需的定量分析的準確性。這項技術進步使製藥公司能夠在分散式臨床試驗中採用遠端採樣，同時保持數據完整性，提高受試者的保留率和可及性。產業績效也印證了這種精準方法的經濟可行性。 Trajan集團控股有限公司在其2025年2月的財務報告中宣布，其負責微量採樣產品系列的「創新技術事業部」上半年營收達220萬美元，證實了市場對這些先進解決方案的持續需求。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球毛細血管採血裝置市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品（採血針、微型採血管、微型血球比容管、加溫裝置、其他）
    • 依材質（塑膠、玻璃、不鏽鋼、陶瓷等）
    • 依應用領域（醫院/診所、捐血中心、診斷中心、家庭診斷、病理檢查室）
    • 依應用題項（全血、血漿/血清蛋白檢測、綜合代謝指標（CMP）檢測、肝功能檢測/肝功能分析/肝功能檢查、乾血斑檢測）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美毛細血管採血設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章 歐洲毛細血管採血裝置市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章 亞太地區毛細血管採血設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲毛細血管採血裝置市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲毛細血管採血裝置市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球毛細血管採血設備市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Becton, Dickinson and Company
  • Greiner Bio-One International GmbH
  • Sarstedt Ag & Co. KG
  • Terumo Medical Corporation
  • B. Braun Melsungen AG
  • Guangzhou Improve Medical Instruments Co., Ltd
  • Abbott Laboratories Inc.
  • Cardinal Health, inc
  • Retractable Technologies, Inc.
  • Haemonetics Corporation

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 27308

The Global Capillary Blood Collection Devices Market is projected to expand from a valuation of USD 2.72 billion in 2025 to USD 4.27 billion by 2031, reflecting a compound annual growth rate of 7.81%. These devices, comprising sterile tools like lancets and micro-collection tubes, are engineered to extract minute blood volumes from sites such as the fingertip, heel, or earlobe for diagnostic purposes. They play a pivotal role in minimally invasive point-of-care testing and patient self-management routines. Market momentum is primarily sustained by the escalating global burden of chronic conditions that demand frequent monitoring, alongside a broader shift toward decentralized healthcare services. This increasing demand is highlighted by the sheer prevalence of diseases requiring regular tracking; for instance, the International Diabetes Federation estimated that 589 million adults globally were living with diabetes in 2024.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 2.72 Billion
Market Size 2031USD 4.27 Billion
CAGR 2026-20317.81%
Fastest Growing SegmentLancets
Largest MarketNorth America

Despite these drivers, the market encounters substantial obstacles related to sample volume limitations and integrity when compared to venous collection methods. Capillary samples are prone to pre-analytical complications, including hemolysis and contamination by interstitial fluid, which can negatively impact diagnostic precision. These technical constraints limit the applicability of capillary collection for complex assays that necessitate larger, high-quality samples. Consequently, healthcare providers are often forced to rely on traditional venipuncture for comprehensive clinical assessments, effectively preventing the complete replacement of venous blood draws with capillary alternatives.

Market Driver

The escalating prevalence of infectious diseases worldwide acts as a major engine for the capillary blood collection devices market, particularly by driving the need for rapid diagnostic tests capable of using finger-prick samples. These minimally invasive instruments are indispensable for mass screening programs in resource-constrained environments where traditional venous draws are often too expensive or logistically difficult. Management of vector-borne diseases relies heavily on lateral flow assays using capillary blood for immediate confirmation and monitoring. The scale of this dependency is evidenced by the massive burden of infection; the World Health Organization's 'World Malaria Report 2023' estimated 249 million global malaria cases in 2022, a figure that directly supports the high-volume use of safety lancets and micro-collection tubes.

Simultaneously, the proliferation of point-of-care testing and decentralized diagnostics is fundamentally altering consumption trends for capillary devices. Healthcare systems are increasingly moving screening procedures out of central labs to enhance patient access and speed up clinical decisions, resulting in a surge in demand for simplified collection kits. This shift is motivated by the critical need to address diagnostic gaps in viral diseases; the World Health Organization's 'Global Hepatitis Report 2024' noted that only 36% of individuals with hepatitis C had been diagnosed, underlining a significant need for accessible capillary-based screening. The industry supporting these efforts operates on a massive scale, as demonstrated by Becton, Dickinson and Company, which reported $5.13 billion in revenue for its Life Sciences segment in 2023.

Market Challenge

The central hurdle inhibiting the growth of the Global Capillary Blood Collection Devices Market involves persistent difficulties regarding sample integrity and restricted volume inherent in capillary sampling. In contrast to venous draws, capillary blood is significantly more susceptible to hemolysis and interstitial fluid contamination caused by the tissue compression necessary during collection. These pre-analytical defects severely degrade specimen quality, frequently making samples inadequate for sensitive clinical assays that require high precision and larger volumes. As a result, medical providers often hesitate to utilize these devices for comprehensive diagnostic panels, limiting their application primarily to glucose monitoring and basic screening.

These technical shortcomings directly obstruct market expansion by precluding the total replacement of traditional venipuncture in clinical environments. The potential for diagnostic inaccuracy compels laboratories to reject compromised samples, leading to repeated draws that elevate patient discomfort and operational expenses. The gravity of this issue is highlighted by recent industry data; according to ECRI in 2024, roughly 23% of diagnostic errors were linked to technical or processing failures, including specimen quality issues. Such high error rates associated with improper sample handling reinforce the reluctance of medical professionals to fully transition to capillary collection systems for critical healthcare decisions.

Market Trends

The rise of Vacuum-Assisted Upper Arm Collection Devices marks a significant market advancement, effectively mitigating the historical limitations regarding volume and quality associated with fingerstick sampling. Distinct from traditional lancets that depend on tissue compression, these innovative devices apply negative pressure to extract capillary blood from the upper arm, yielding larger, lab-quality specimens comparable to venous draws. This functionality supports a structural shift from clinic-based phlebotomy toward patient-centric remote collection, specifically for chronic disease panels needing serum or plasma volumes beyond standard capillary capabilities. The commercial success of this technology is reflected in its rapid adoption; Tasso, Inc. announced in a March 2025 press release that it had sold over 1.5 million of its patient-centric devices, signaling growing acceptance of this method for remote diagnostics.

In parallel, the integration of Volumetric Absorptive Microsampling (VAMS) Technology is transforming dried blood sampling by eliminating the hematocrit bias common in traditional filter paper techniques. VAMS devices capture a fixed, precise blood volume regardless of viscosity, guaranteeing analytical accuracy for quantitative assays essential to therapeutic drug monitoring and pharmaceutical development. This technological improvement enables pharmaceutical firms to incorporate remote sampling into decentralized clinical trials while maintaining data integrity, thereby enhancing participant retention and access. The financial viability of this precise approach is evidenced by sector performance; Trajan Group Holdings Limited reported in its February 2025 financial results that its Disruptive Technologies segment, housing the microsampling portfolio, achieved $2.2 million in half-year revenue, confirming sustained demand for these advanced solutions.

Key Market Players

  • Becton, Dickinson and Company
  • Greiner Bio-One International GmbH
  • Sarstedt Ag & Co. KG
  • Terumo Medical Corporation
  • B. Braun Melsungen AG
  • Guangzhou Improve Medical Instruments Co., Ltd
  • Abbott Laboratories Inc.
  • Cardinal Health, inc
  • Retractable Technologies, Inc.
  • Haemonetics Corporation

Report Scope

In this report, the Global Capillary Blood Collection Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Capillary Blood Collection Devices Market, By Product

  • Lancets
  • Micro-container Tubes
  • Micro-hematocrit Tubes
  • Warming Devices
  • Others

Capillary Blood Collection Devices Market, By Material

  • Plastic
  • Glass
  • Stainless Steel
  • Ceramic
  • Others

Capillary Blood Collection Devices Market, By End Use

  • Hospitals & Clinics
  • Blood Donation Centers
  • Diagnostic Centers
  • Home Diagnosis
  • Pathology Laboratories

Capillary Blood Collection Devices Market, By Application

  • Whole Blood
  • Plasma/ Serum Protein Tests
  • Comprehensive Metabolic Panel (CMP) Tests
  • Liver Panel / Liver Profile/ Liver Function Tests
  • Dried Blood Spot Tests

Capillary Blood Collection Devices Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Capillary Blood Collection Devices Market.

Available Customizations:

Global Capillary Blood Collection Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Capillary Blood Collection Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Lancets, Micro-container Tubes, Micro-hematocrit Tubes, Warming Devices, Others)
    • 5.2.2. By Material (Plastic, Glass, Stainless Steel, Ceramic, Others)
    • 5.2.3. By End Use (Hospitals & Clinics, Blood Donation Centers, Diagnostic Centers, Home Diagnosis, Pathology Laboratories)
    • 5.2.4. By Application (Whole Blood, Plasma/ Serum Protein Tests, Comprehensive Metabolic Panel (CMP) Tests, Liver Panel / Liver Profile/ Liver Function Tests, Dried Blood Spot Tests)
    • 5.2.5. By Region
    • 5.2.6. By Company (2025)
  • 5.3. Market Map

6. North America Capillary Blood Collection Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Material
    • 6.2.3. By End Use
    • 6.2.4. By Application
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Capillary Blood Collection Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Material
        • 6.3.1.2.3. By End Use
        • 6.3.1.2.4. By Application
    • 6.3.2. Canada Capillary Blood Collection Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Material
        • 6.3.2.2.3. By End Use
        • 6.3.2.2.4. By Application
    • 6.3.3. Mexico Capillary Blood Collection Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Material
        • 6.3.3.2.3. By End Use
        • 6.3.3.2.4. By Application

7. Europe Capillary Blood Collection Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Material
    • 7.2.3. By End Use
    • 7.2.4. By Application
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Capillary Blood Collection Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Material
        • 7.3.1.2.3. By End Use
        • 7.3.1.2.4. By Application
    • 7.3.2. France Capillary Blood Collection Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Material
        • 7.3.2.2.3. By End Use
        • 7.3.2.2.4. By Application
    • 7.3.3. United Kingdom Capillary Blood Collection Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Material
        • 7.3.3.2.3. By End Use
        • 7.3.3.2.4. By Application
    • 7.3.4. Italy Capillary Blood Collection Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Material
        • 7.3.4.2.3. By End Use
        • 7.3.4.2.4. By Application
    • 7.3.5. Spain Capillary Blood Collection Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Material
        • 7.3.5.2.3. By End Use
        • 7.3.5.2.4. By Application

8. Asia Pacific Capillary Blood Collection Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Material
    • 8.2.3. By End Use
    • 8.2.4. By Application
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Capillary Blood Collection Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Material
        • 8.3.1.2.3. By End Use
        • 8.3.1.2.4. By Application
    • 8.3.2. India Capillary Blood Collection Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Material
        • 8.3.2.2.3. By End Use
        • 8.3.2.2.4. By Application
    • 8.3.3. Japan Capillary Blood Collection Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Material
        • 8.3.3.2.3. By End Use
        • 8.3.3.2.4. By Application
    • 8.3.4. South Korea Capillary Blood Collection Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Material
        • 8.3.4.2.3. By End Use
        • 8.3.4.2.4. By Application
    • 8.3.5. Australia Capillary Blood Collection Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Material
        • 8.3.5.2.3. By End Use
        • 8.3.5.2.4. By Application

9. Middle East & Africa Capillary Blood Collection Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Material
    • 9.2.3. By End Use
    • 9.2.4. By Application
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Capillary Blood Collection Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Material
        • 9.3.1.2.3. By End Use
        • 9.3.1.2.4. By Application
    • 9.3.2. UAE Capillary Blood Collection Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Material
        • 9.3.2.2.3. By End Use
        • 9.3.2.2.4. By Application
    • 9.3.3. South Africa Capillary Blood Collection Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Material
        • 9.3.3.2.3. By End Use
        • 9.3.3.2.4. By Application

10. South America Capillary Blood Collection Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Material
    • 10.2.3. By End Use
    • 10.2.4. By Application
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Capillary Blood Collection Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Material
        • 10.3.1.2.3. By End Use
        • 10.3.1.2.4. By Application
    • 10.3.2. Colombia Capillary Blood Collection Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Material
        • 10.3.2.2.3. By End Use
        • 10.3.2.2.4. By Application
    • 10.3.3. Argentina Capillary Blood Collection Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Material
        • 10.3.3.2.3. By End Use
        • 10.3.3.2.4. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Capillary Blood Collection Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Becton, Dickinson and Company
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Greiner Bio-One International GmbH
  • 15.3. Sarstedt Ag & Co. KG
  • 15.4. Terumo Medical Corporation
  • 15.5. B. Braun Melsungen AG
  • 15.6. Guangzhou Improve Medical Instruments Co., Ltd
  • 15.7. Abbott Laboratories Inc.
  • 15.8. Cardinal Health, inc
  • 15.9. Retractable Technologies, Inc.
  • 15.10. Haemonetics Corporation

16. Strategic Recommendations

17. About Us & Disclaimer